Filed: 8/14/2023ACC: 0000950123-23-007696
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $178.49M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$178.49M
Total AUM (reported)
32.43M
Total Shares
Allocation by class
COMMON STOCK$151.36M84.8%
COMMON STOCK CLASS A$27.13M15.2%
Portfolio Concentration
Top 3$117.68M65.9%
4–10$59.89M33.6%
11–25$914.3K0.5%
Top 3 weight
65.9%
Top 10 weight
99.5%
Voting Authority Distribution
Total shares with voting rights: 32.43M
Sole
Full voting authority
32.43M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
Replimune Group
SOLEShares3M
TypeSH
Market value$69.69M
39.05%
Sole
3M
Shared
0.00
None
0.00
Nuvation Bio
SOLEShares15.07M
TypeSH
Market value$27.13M
15.20%
Sole
15.07M
Shared
0.00
None
0.00
Alpine Immune Sciences
SOLEShares2.03M
TypeSH
Market value$20.86M
11.69%
Sole
2.03M
Shared
0.00
None
0.00
Morphic Holding
SOLEShares309.85K
TypeSH
Market value$17.76M
9.95%
Sole
309.85K
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$14.75M
8.27%
Sole
2.25M
Shared
0.00
None
0.00
Theseus Pharmaceuticals
SOLEShares711.48K
TypeSH
Market value$6.64M
3.72%
Sole
711.48K
Shared
0.00
None
0.00
Kronos Bio
SOLEShares3.82M
TypeSH
Market value$6.57M
3.68%
Sole
3.82M
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$5.03M
2.82%
Sole
843.75K
Shared
0.00
None
0.00
Spruce Biosciences
SOLEShares2.16M
TypeSH
Market value$4.65M
2.60%
Sole
2.16M
Shared
0.00
None
0.00
Immunic Inc
SOLEShares1.79M
TypeSH
Market value$4.49M
2.51%
Sole
1.79M
Shared
0.00
None
0.00
Syros Pharmaceuticals
SOLEShares251.27K
TypeSH
Market value$791.5K
0.44%
Sole
251.27K
Shared
0.00
None
0.00
Senti Biosciences, Inc.
SOLEShares195.79K
TypeSH
Market value$122.8K
0.07%
Sole
195.79K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Replimune GroupSOLE | Common Stock | 3M | SH | $69.69M 39.05% | 3M | 0.00 | 0.00 |
Nuvation BioSOLE | Common Stock Class A | 15.07M | SH | $27.13M 15.20% | 15.07M | 0.00 | 0.00 |
Alpine Immune SciencesSOLE | Common Stock | 2.03M | SH | $20.86M 11.69% | 2.03M | 0.00 | 0.00 |
Morphic HoldingSOLE | Common Stock | 309.85K | SH | $17.76M 9.95% | 309.85K | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $14.75M 8.27% | 2.25M | 0.00 | 0.00 |
Theseus PharmaceuticalsSOLE | Common Stock | 711.48K | SH | $6.64M 3.72% | 711.48K | 0.00 | 0.00 |
Kronos BioSOLE | Common Stock | 3.82M | SH | $6.57M 3.68% | 3.82M | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $5.03M 2.82% | 843.75K | 0.00 | 0.00 |
Spruce BiosciencesSOLE | Common Stock | 2.16M | SH | $4.65M 2.60% | 2.16M | 0.00 | 0.00 |
Immunic IncSOLE | Common Stock | 1.79M | SH | $4.49M 2.51% | 1.79M | 0.00 | 0.00 |
Syros PharmaceuticalsSOLE | Common Stock | 251.27K | SH | $791.5K 0.44% | 251.27K | 0.00 | 0.00 |
Senti Biosciences, Inc.SOLE | Common Stock | 195.79K | SH | $122.8K 0.07% | 195.79K | 0.00 | 0.00 |